Loading...
Aclarion, Inc.
ACON•NASDAQ
Healthcare
Medical - Healthcare Information Services
$7.47
$0.15(1.98%)
Aclarion, Inc. (ACON) Financial Performance & Income Statement Overview
Review Aclarion, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-39.36%
↓ 39.36%
Operating Income Growth
-13.07%
↓ 13.07%
Net Income Growth
-42.38%
↓ 42.38%
Operating Cash Flow Growth
-44.55%
↓ 44.55%
Operating Margin
-10493.70%
↓ 10493.70%
Gross Margin
-62.38%
↓ 62.38%
Net Profit Margin
-12144.94%
↓ 12144.94%
ROE
-126.90%
↓ 126.90%
ROIC
-36.31%
↓ 36.31%
Aclarion, Inc. (ACON) Income Statement & Financial Overview
Review Aclarion, Inc.'s (ACON) income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $18991.00 | $10232.00 | $14407.00 | $10971.00 |
Cost of Revenue | $23479.00 | $20556.00 | $21332.00 | $23294.00 |
Gross Profit | -$4488.00 | -$10324.00 | -$6925.00 | -$12323.00 |
Gross Profit Ratio | -$0.24 | -$1.009 | -$0.48 | -$1.12 |
R&D Expenses | $198190.00 | $251826.00 | $195797.00 | $202102.00 |
SG&A Expenses | $1.29M | $1.54M | $1.09M | $921136.00 |
Operating Expenses | $1.49M | $1.80M | $1.29M | $1.12M |
Total Costs & Expenses | $1.51M | $1.82M | $1.31M | $1.15M |
Interest Income | $0.00 | $318.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $271.00 | $71527.00 | $127848.00 |
Depreciation & Amortization | $0.00 | $52245.00 | $50029.00 | $45755.00 |
EBITDA | -$1.49M | -$1.94M | -$1.24M | -$1.06M |
EBITDA Ratio | -$78.56 | -$189.31 | -$86.39 | -$97.03 |
Operating Income | -$1.49M | -$1.81M | -$1.30M | -$1.14M |
Operating Income Ratio | -$78.56 | -$176.53 | -$89.95 | -$103.51 |
Other Income/Expenses (Net) | -$545511.00 | -$183352.00 | -$70218.00 | -$102516.00 |
Income Before Tax | -$2.04M | -$1.99M | -$1.37M | -$1.24M |
Income Before Tax Ratio | -$107.28 | -$194.45 | -$94.83 | -$112.85 |
Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Net Income | -$2.04M | -$1.99M | -$1.37M | -$1.24M |
Net Income Ratio | -$107.28 | -$194.45 | -$94.83 | -$112.85 |
EPS | -$0.93 | -$0.21 | -$0.14 | -$0.15 |
Diluted EPS | -$0.93 | -$0.21 | -$0.14 | -$0.15 |
Weighted Avg Shares Outstanding | $2.19M | $9.44M | $9.44M | $8.22M |
Weighted Avg Shares Outstanding (Diluted) | $2.19M | $9.44M | $9.44M | $8.22M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan